1. Home
  2. HLX vs HRMY Comparison

HLX vs HRMY Comparison

Compare HLX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$10.05

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$26.57

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
HRMY
Founded
1979
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HLX
HRMY
Price
$10.05
$26.57
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$10.50
$46.70
AVG Volume (30 Days)
1.7M
644.8K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
0.21
2.71
Revenue
$876,561,000.00
$868,453,000.00
Revenue This Year
$2.91
$19.75
Revenue Next Year
$4.97
$12.88
P/E Ratio
$48.02
$10.12
Revenue Growth
3.60
21.51
52 Week Low
$5.52
$25.52
52 Week High
$10.75
$40.87

Technical Indicators

Market Signals
Indicator
HLX
HRMY
Relative Strength Index (RSI) 65.97 30.23
Support Level $6.20 $25.71
Resistance Level $10.75 $28.99
Average True Range (ATR) 0.32 0.70
MACD 0.05 0.17
Stochastic Oscillator 92.84 0.61

Price Performance

Historical Comparison
HLX
HRMY

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: